HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-Positive Metastatic Breast CancerGENERAL SESSION 2 | THURSDAY, DECEMBER 7 | 8:15AM-11:15AM CT
Trastuzumab Emtansine;Tucatinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-Positive Metastatic Breast CancerGENERAL SESSION 2 | THURSDAY, DECEMBER 7 | 8:15AM-11:15AM CT ### Output: Trastuzumab Emtansine;Tucatinib